Showing results (1-10 of 251) with videos related to
Sort By:
Pageof 26
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Molecular defects in colorectal tumorigenesisS Tejpar, E van CutsemActa Gastro-Enterologica Belgica|October 30, 2001
The molecular basis of colorectal cancerS Tejpar, J J Cassiman, E Van CutsemActa Gastro-Enterologica Belgica|September 1, 1995
Screening for colorectal cancerE Van Cutsem, S Tejpar, P Rutgeerts, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)H Piessevaux, M Buyse, W De Roock, et al.Familial Cancer|June 1, 2006
Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patientsM Spaepen, B Vankeirsbilck, S Van Opstal, et al.European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectivesE Van CutsemEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1996
A glimpse of the future. new directions in the treatment of colorectal cancerE Van CutsemActa Gastro-Enterologica Belgica|January 1, 1993
Georges Brohee Prize. Oestrogen-progesterone, a new therapy of bleeding gastrointestinal vascular malformationsE Van CutsemPageof 26